ArticleBMC cancer2013

N-glycosylation of ICAM-2 is required for ICAM-2-mediated complete suppression of metastatic potential of SK-N-AS neuroblastoma cells.

Joseph M Feduska et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.